One of the most important ways to advance medicine is clinical research. In 2007, FCCI established a clinical research department that has since enrolled nearly 3,000 patients. Housing research allows our patients to be the first to benefit from exciting new technology in the field.
FCCI is proud to be taking part in the following research studies:
V-Wave Interatrial Shunt
This is a minimally-invasive implanted interatrial shunt device intended for treating patients with severe symptomatic heart failure. The shunt is designed to regulate left atrial pressure, providing symptom relief, decreasing hospitalization, and improving quality of life.
CardioMEMS HF System
This device is implanted in your pulmonary artery and takes daily pressure readings from the comfort of your home. The data is then sent wirelessly to your doctor for constant monitoring. The sensor is small and does not require any batteries or wires and does not interfere with any daily activities. This device has helped dramatically reduce heart failure-related hospitalizations.
This is the world’s first FDA drug-eluting peripheral stent. Drug-eluting stents are small mesh tubes with a coating that expends a drug over time to keep blockages from coming back. Silver PTX is used for the treatment of restenosis in above-the-knee femoropopliteal arteries.
FCCI is the first clinic in Florida to perform the Detour procedure. It is intended for patients suffering from peripheral arterial disease with a blockage in the main artery of the thigh. The procedure provides a new way for blood to travel down the leg.
This blood thinner is intended to treat and prevent blood clotting. Xarelto is proven to further reduce the risk of cardiovascular events in people with chronic peripheral artery disease.
As a patient at FCCI, you may be asked to participate in a research study. A member of our Research Department will review the study with you and answer any questions you may have. To learn more, call our office at 904.493.3333.